AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
MCM.MC

Miquel y Costas & Miquel, S.A. (MCM.MC) fair value

Basic Materials · Paper & Paper Products · BME · Spain
€9.82+0.82%
Market cap €439MNext earnings 2025-05-09Updated Oct 23, 2026
Our verdict
Trades 17% below our fair value
Price
€9.82
Model fair valueConfidence: good
€11.83
Model range
€3.01 to €15.49
Fair value €11.83
Price €9.82
4 models fit Miquel y Costas & Miquel, S.A. and they disagree: 0 of 4 land within 15% of the average.
Two or more of our models back this value.
Discount(i)Bronze40
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionMiquel y Costas & Miquel, S.A. (MCM.MC)
Fair value (4 models)
€11.83
ACCE price target
€10.10
Rating
Undervalued
Horizon
12 months
Fair value published on 23 Oct 2026, 11:04 CEST.
ACCE price target published on 23 Oct 2026, 01:53 CEST.
Rating published on 23 Oct 2026, 11:04 CEST.
Price used: €9.82 at the close on 23 Oct 2026, 17:30 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
17.0% below
+20.4% to fair value
ACCE score
46
out of 100
P/E
11.2x
1-year return
-12.7%
Dividend yield
3.95%

Miquel y Costas & Miquel, S.A. in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Miquel y Costas & Miquel is a Barcelona-listed maker of premium paper and tissue, selling branded and private-label products that include cigarette and specialty papers alongside its consumer hygiene lines. The moat is less about scale than about a 62.2% gross margin, which points to pricing power in niche grades rather than commodity pulp. Revenue is roughly flat (down 0.2%), so growth has to come from mix and margin, not volume, and there is no named catalyst in the data we have. At an 11.1x trailing P/E, a 9.7% ROE and a 14.3% operating margin, the stock screens as a cash-generative small cap that the market is not paying much for. It is a €436M market cap with no index membership and no forward estimates, so the first question for a deeper look is whether the margin is durable or cyclical.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where MCM.MC's valuation models land
Price
€9.82
Model fair value
€11.83
Model range
€3.01 to €15.49
Fair value €11.83
Price €9.82
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-2.8%
1 month
-8.7%
3 months
-14.6%
6 months
-15.9%
YTD
-18.2%
1 year
-12.7%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 11:04 CESTFair value€11.83first publication€9.74
23 Oct 2026, 11:04 CESTRatingUndervaluedfirst publication€9.74
23 Oct 2026, 01:53 CESTACCE price target€10.10first publication€9.74

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full MCM.MC page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value79Quality74Momentum25Total46
Valuation
Trailing P/E
11.2x
Forward P/E
no data
PEG
no data
P/B
1.18x
EV / Revenue
1.6x
Book value/sh
€9.16
Enterprise value
€496M
Profitability
ROE
9.7%
FCF yield
2.71%
ROIC
8.1%
Health and risk
Debt / equity
0.12
Dividend yield
3.95%
Beta
0.15

Price

-12.7% · 1Y

Ask anything about MCM.MC

Answered from Miquel y Costas & Miquel, S.A. fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 80% of peers
low 0.0x11.2xhigh 830.0x
ROEbetter than 83% of peers
low -13%10%high 10%
Div yieldbetter than 83% of peers
low 0.0%4.0%high 5.8%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
MCM.MC Miquel y Costas & Miquel, S.A.€9.82€1217% below11.2x9.7%7446
CPHN.SW CPH Group AGCHF 56.80CHF 4236% above16.7x10.1%6744
ENC.MC ENCE Energía y Celulosa, S.A.€2.20----12.8%3934
CLW Clearwater Paper Corporation Common Stock$19.04----10.4%2739
ALTR.LS Altri, SGPS, S.A.€4.26€338% above71.0x2.8%3444
2002.HK China Sunshine Paper Holdings Company LimitedHK$1.71HK$454% below12.4x2.9%2558
IBG.MC Iberpapel Gestión, S.A.€16.60€2739% below830.0x0.0%4646

Sector report card

Where MCM.MC ranks against its sector peers on each metric.

Computing percentiles…